These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1979179)

  • 1. Synergistic effects between D-1 and D-2 dopamine antagonists on catalepsy in rats.
    Wanibuchi F; Usuda S
    Psychopharmacology (Berl); 1990; 102(3):339-42. PubMed ID: 1979179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D1/D2 dopamine and N-methyl-D-aspartate (NMDA) receptor participation in experimental catalepsy in rats.
    Verma A; Kulkarni SK
    Psychopharmacology (Berl); 1992; 109(4):477-83. PubMed ID: 1365866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catalepsy induced by SCH 23390 in rats.
    Morelli M; Di Chiara G
    Eur J Pharmacol; 1985 Nov; 117(2):179-85. PubMed ID: 2866970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice.
    Boulay D; Depoortere R; Oblin A; Sanger DJ; Schoemaker H; Perrault G
    Eur J Pharmacol; 2000 Mar; 391(1-2):63-73. PubMed ID: 10720636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
    Arnt J
    Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
    Parashos SA; Marin C; Chase TN
    Neurosci Lett; 1989 Oct; 105(1-2):169-73. PubMed ID: 2485878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
    Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
    Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic blockade of some dopamine-mediated behaviours by (-)-sulpiride and SCH 23390 in the rat.
    Dall'Olio R; Roncada P; Vaccheri A; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1989; 98(3):342-6. PubMed ID: 2568655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further studies of the mechanism behind scopolamine-induced reversal of antistereotypic and cataleptogenic effects of neuroleptics in rats.
    Arnt J; Hyttel J; Bach-Lauritsen T
    Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):319-24. PubMed ID: 2879412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine A2 receptors modulate haloperidol-induced catalepsy in rats.
    Mandhane SN; Chopde CT; Ghosh AK
    Eur J Pharmacol; 1997 Jun; 328(2-3):135-41. PubMed ID: 9218695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats.
    Wadenberg MG; Browning JL; Young KA; Hicks PB
    Pharmacol Biochem Behav; 2001 Mar; 68(3):363-70. PubMed ID: 11325387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalepsy-associated behavior induced by dopamine D1 receptor antagonists and partial dopamine D1 receptor agonists in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    Eur J Pharmacol; 1994 Aug; 260(2-3):237-41. PubMed ID: 7988649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic methamphetamine on SCH23390- or haloperidol-induced catalepsy, and effects of coadministration of SCH23390 or haloperidol in mice.
    Mizuki Y; Ushijima I; Yamada M
    Pharmacol Biochem Behav; 1996 Feb; 53(2):437-40. PubMed ID: 8808155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel antipsychotic agents with 5-HT(1A) agonist properties: role of 5-HT(1A) receptor activation in attenuation of catalepsy induction in rats.
    Kleven MS; Barret-Grévoz C; Bruins Slot L; Newman-Tancredi A
    Neuropharmacology; 2005 Aug; 49(2):135-43. PubMed ID: 15996562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-1 and D-2 receptor blockade have additive cataleptic effects in mice, but receptor effects may interact in opposite ways.
    Klemm WR; Block H
    Pharmacol Biochem Behav; 1988 Feb; 29(2):223-9. PubMed ID: 3283778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists.
    Papa SM; Engber TM; Boldry RC; Chase TN
    Eur J Pharmacol; 1993 Mar; 232(2-3):247-53. PubMed ID: 8385618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of buspirone on dopamine dependent behaviours in rats.
    Dhavalshankh AG; Jadhav SA; Gaikwad RV; Gaonkar RK; Thorat VM; Balsara JJ
    Indian J Physiol Pharmacol; 2007; 51(4):375-86. PubMed ID: 18476392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antipsychotic-like vs cataleptogenic actions in mice of novel antipsychotics having D2 antagonist and 5-HT1A agonist properties.
    Bardin L; Kleven MS; Barret-Grévoz C; Depoortère R; Newman-Tancredi A
    Neuropsychopharmacology; 2006 Sep; 31(9):1869-79. PubMed ID: 16237379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The D2 dopamine receptor agonist LY171555 induces catalepsy in the mouse.
    Puglisi-Allegra S; Cabib S
    Pharmacol Biochem Behav; 1988 Jul; 30(3):765-8. PubMed ID: 2974996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.